Company: Sarepta
Project: Aggregate market research and stakeholder experience mapping for web and operations GTM plan in preparation for FDA accelerated approval and launch.
Audience: Supply Chain, Patient, Families, Prescribing HCP’s, Treating HCP’s, Insurance
Teams: C-Level, Sales, Strategy, Copy, Design, UX, Dev
Synopsis: Sarepta brought the first Duchene Muscular Dystrophy treatment to market in the form of a one-time, iv administered gene therapy with a price tag of $2.91M. We were engaged to prepare and deliver the product launch and delivery experience. With 5 distinct audiences, the challenge was to absorb what teams of trained medical and clinical professionals are trained to know and distill it to these audiences in their language. Details like the requirement to collect accurate weight data of patients who are all in different wheelchairs are but one of the unique variances that can only be learned through discovery with boots on the ground experts.
Project Highlights:
- Workshops:
- Scientists
- Care facilities
- Administrating nurses
- Insurance & payment
- Families
- Adverse events
- Delivery, Storage, Handling SOPs:
- Drug requires freezing at all times
- If vial gets broken – process for reporting and remediation
Outputs Clinic/Web:
- Solution and presentation decks
- Web
- Ebooks and user guides
Links: